Company News in the Life Science Industry

»

Reset 

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019

Read more ››
By: GlobenewsWire - 13 Jan 2020

Autolus Therapeutics to provide outlook for 2020 at the 38th Annual J.P. Morgan Conference

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Autolus Therapeutics plc

Venus Concept Announces Preliminary Fourth Quarter and Fiscal Year 2019 Revenue Results; Introduces Fiscal Year 2020 Revenue Guidance

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Restoration Robotics, Inc.

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  AxoGen, Inc.

Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Cyclerion Therapeutics, Inc.

Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Medicure Inc.

Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Aeglea BioTherapeutics

Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Amicus Therapeutics, Inc.

CareDx Reports Preliminary Fourth Quarter and Full Year 2019 Results

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  CareDx, Inc.

Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Cyclacel Pharmaceuticals, Inc.

Orchard Therapeutics Highlights 2020 Strategic Priorities

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Orchard Therapeutics Limited

Neovasc Inc. Investor Update

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Neovasc Inc.

Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Precision BioSciences Inc.

Replimune Provides 2019 Year End Corporate Update and Reviews Expected 2020 Milestones

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Replimune Inc.

Organogenesis Holdings Inc. Reports Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2019

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Organogenesis Inc.

Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Calithera Biosciences, Inc.

Momenta Provides Year-End 2019 Update and 2020 Outlook

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Momenta Pharmaceuticals, Inc.

BridgeBio Pharma Grows Pipeline to 20+ Genetic Medicines with Four Assets Focused on Treating Genetically Driven Diseases at Their Source

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  BridgeBio Inc.

T2 Biosystems Promotes Tony Pare to Chief Commercial Officer

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  T2 Biosystems, Inc.

MacroGenics to Present at the J.P. Morgan Healthcare Conference

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  MacroGenics, Inc
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies